Panacea Biotec Faces Rs 5.75 Crore GST Demand
By Rediff Money Desk, New Delhi Aug 20, 2024 14:05
Panacea Biotec received a Rs 5.75 crore GST demand in Mumbai for the sale of its leasehold land and building in Navi Mumbai. The company disputes the demand and plans to appeal.
New Delhi, Aug 20 (PTI) Vaccines maker Panacea Biotec Ltd on Tuesday said it has received a demand of nearly Rs 5.75 crore from GST authority in Mumbai on the sale of its leasehold land and building in Navi Mumbai.
The company has received a demand order dated August 19, 2024, from the office of the Assistant Commissioner of State Tax, Mumbai raising a demand of Rs 5,74,53,146 towards the balance amount of GST, including interest and penalty, on the sale of leasehold land and building in Navi Mumbai, Panacea Biotec said in a regulatory filing.
The order has alleged that the transaction is a sub-lease transaction, it added.
The company had earlier deposited an amount of Rs 3,14,17,862 under protest in April 2024 and has also filed a writ petition before the Bombay High Court in this regard, Panacea Biotec said.
Based on its assessment, the company said the "demand is not maintainable" and it is taking all necessary steps, including evaluating the option of filing an appeal against the demand, it said, adding it does not envisage any relevant impact on its financial, operation or other activities.
The company has received a demand order dated August 19, 2024, from the office of the Assistant Commissioner of State Tax, Mumbai raising a demand of Rs 5,74,53,146 towards the balance amount of GST, including interest and penalty, on the sale of leasehold land and building in Navi Mumbai, Panacea Biotec said in a regulatory filing.
The order has alleged that the transaction is a sub-lease transaction, it added.
The company had earlier deposited an amount of Rs 3,14,17,862 under protest in April 2024 and has also filed a writ petition before the Bombay High Court in this regard, Panacea Biotec said.
Based on its assessment, the company said the "demand is not maintainable" and it is taking all necessary steps, including evaluating the option of filing an appeal against the demand, it said, adding it does not envisage any relevant impact on its financial, operation or other activities.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Zomato
- 263.00 (+ 0.27)
- 210300584
- GTL Infrastructure
- 2.81 ( -2.09)
- 29254970
- Vodafone Idea L
- 15.94 ( -0.13)
- 28664688
- Filatex Fashions
- 1.35 (+ 1.50)
- 26589865
- Ola Electric Mobilit
- 137.72 ( -5.69)
- 20176730
MORE NEWS
![RBI Inflation...](https://im.rediff.com/80-80/money/2021/feb/26inflation.jpg)
RBI Inflation Targeting: Research Paper Says...
A new research paper argues that abandoning the RBI's inflation targeting regime would...
![Indian Cos Capex:...](https://im.rediff.com/80-80/money/2021/dec/01oil.jpg)
Indian Cos Capex: USD 45-50 Billion Over 2...
Moody's forecasts Indian companies to spend USD 45-50 billion annually on capex over...
![Axiscades...](https://im.rediff.com/80-80/money/2016/jun/08energy.jpg)
Axiscades Subsidiary Wins UK Energy Storage...
Axiscades subsidiary Epcogen has secured a contract from Highview Power to build the...